Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive
In this episode, we sat down with Paul Andreola, from Smallcap Discoveries, whom is also a director of ImmunoPrecise Antibodies
Read more
ImmunoPrecise Antibodies Ltd
ImmunoPrecise Antibodies Set To Begin Trading On Nasdaq December 30
ImmunoPrecise Antibodies (TSXV: IPA) (NASDAQ: IPA) has officially been approved for listing on the Nasdaq Global Markets. The company announced
Read more
Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating
COVID-19 related stocks are all the rage this morning, however it appears to be for the wrong reason. Following the
Read more
ImmunoPrecise Begins Pre-Clinical Trials For SARS-CoV-2 Vaccine
ImmunoPrecise Antibodies (TSXV: IPA) and its partner LiteVax BV jointly announced this morning that they have begun pre-clinical trials for
Read more
ImmunoPrecise Insider Sells $1.9 Million Worth Of Shares Over Three Days
ImmunoPrecise Antibodies Ltd (TSXV: IPA) has seen continued insider selling over the last several days. Monday night, insider Miko Malberg,
Read more
ImmunoPrecise Begins Path to NASDAQ
This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on
Read more
ImmunoPrecise Repays $2.75 Million In Debt, Sees $3.8 Million In Warrants Exercised
ImmunoPrecise Antibodies (TSXV: IPA) announced this morning that it has managed to remove outstanding convertible debenture debt from its balance
Read more
ImmunoPrecise Posts Third Quarter Revenues of $4.0 Million
ImmunoPrecise Antibodies Ltd (TSXV: IPA), a therapeutic antibody and vaccine research company has released its financial results for the third
Read more